Zhe-Sheng Chen
Affiliations: | St. John's University (New York), School of Pharmacy |
Area:
Cell Biology, Molecular Biology, PharmacologyGoogle:
"Zhe-Sheng Chen"Children
Sign in to add traineeXing-Xiang Peng | grad student | 2008 | St. John's University (New York), School of Pharmacy |
Ioana Abraham | grad student | 2012 | St. John's University (New York), School of Pharmacy |
Kamlesh S. Sodani | grad student | 2013 | St. John's University (New York), School of Pharmacy |
Atish Patel | grad student | 2014 | St. John's University (New York), School of Pharmacy |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gao HL, Cui Q, Wang JQ, et al. (2023) The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells. Frontiers in Pharmacology. 14: 1235285 |
Wang J, Zeng L, Wu N, et al. (2023) Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 70: 100985 |
Lei ZN, Tian Q, Teng QX, et al. (2023) Understanding and targeting resistance mechanisms in cancer. Medcomm. 4: e265 |
Xu Y, Wang Z, Zhang L, et al. (2023) Differentiation of imatinib -resistant chronic myeloid leukemia cells with BCR-ABL-T315I mutation induced by Jiyuan Oridonin A. Journal of Cancer. 14: 1182-1194 |
Wen Q, Huang M, Xie J, et al. (2023) lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 69: 100975 |
Zhang DM, Shu C, Chen JJ, et al. (2023) Correction to "BBA, a Derivative of 23-Hydroxybetulinic Acid, Potently Reverses ABCB1-Mediated Drug Resistance and ". Molecular Pharmaceutics. 20: 3249 |
Gao C, Zhang L, Xu Y, et al. (2023) I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibition. Frontiers in Pharmacology. 14: 1183052 |
Lin R, Zhang L, Ye B, et al. (2023) A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency. Cancer Letters. 216181 |
Bo L, Wang Y, Li Y, et al. (2023) The Battlefield of Chemotherapy in Pediatric Cancers. Cancers. 15 |
Ye GJ, Cai CY, Dong XD, et al. (2023) Design, synthesis, and biological evaluation of phenylurea indole derivatives as ABCG2 inhibitors. Bioorganic Chemistry. 135: 106481 |